Literature DB >> 11720790

Na(+)-K(+)-ATPase inhibition and depolarization induce glutamate release via reverse Na(+)-dependent transport in spinal cord white matter.

S Li1, P K Stys.   

Abstract

Excitotoxic mechanisms involving alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionate (AMPA)/kainate receptors play an important role in mediating cellular damage in spinal cord injury. However, the precise cellular mechanisms of glutamate release from non-synaptic white matter are not well understood. We examined how the collapse of transmembrane Na(+) and K(+) gradients induces reverse operation of Na(+)-dependent glutamate transporters, leading to glutamate efflux and injury to rat spinal dorsal columns in vitro. Compound action potentials were irreversibly reduced to 43% of control after ouabain/high K(+)/low Na(+) exposure (500 microM ouabain for 30 min to increase [Na(+)](i), followed by 1 h ouabain+high K(+) (129 mM)/low Na(+) (27 mM), to further reverse transmembrane ion gradients) followed by a 2 h wash. Ca(2+)-free perfusate was very protective (compound action potential amplitude recovered to 87% vs. 43%). The broad spectrum glutamate antagonist kynurenic acid (1 mM) or the selective AMPA antagonist GYKI52466 (30 microM) were partially protective (68% recovery). Inhibition of Na(+)-dependent glutamate transport with L-trans-pyrrolidine-2,4-dicarboxylic acid (1 mM) also provided significant protection (71% recovery), similar to that seen with glutamate receptor antagonists. Blocking reverse Na(+)-Ca(2+) exchange with KB-R7943 (10 microM) however, was ineffective in this paradigm (49% recovery). Semiquantitative glutamate immunohistochemistry revealed that levels of this amino acid were significantly depleted in axon cylinders and, to a lesser degree, in oligodendrocytes (but not in astrocytes) by ouabain/high K(+)/low Na(+), which was largely prevented by glutamate transport inhibition. Our data show that dorsal column white matter contains the necessary glutamate pools and release mechanisms to induce significant injury. When Na(+) and K(+) gradients are disrupted, even in the absence of reduced cellular energy reserves, reverse operation of Na(+)-dependent glutamate transport will release enough endogenous glutamate to activate AMPA receptors and cause substantial Ca(2+)-dependent injury. This mechanism likely plays an important role during ischemic and traumatic white matter injury, where collapse of transmembrane Na(+) and K(+) gradients occurs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11720790     DOI: 10.1016/s0306-4522(01)00385-2

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  23 in total

Review 1.  Na(+),K (+)-ATPase as a docking station: protein-protein complexes of the Na(+),K (+)-ATPase.

Authors:  Linda Reinhard; Henning Tidow; Michael J Clausen; Poul Nissen
Journal:  Cell Mol Life Sci       Date:  2012-06-14       Impact factor: 9.261

2.  Pathology dynamics predict spinal cord injury therapeutic success.

Authors:  Cassie S Mitchell; Robert H Lee
Journal:  J Neurotrauma       Date:  2008-12       Impact factor: 5.269

3.  Anthocyanins control neuroinflammation and consequent memory dysfunction in mice exposed to lipopolysaccharide.

Authors:  Fabiano B Carvalho; Jessié M Gutierres; Andressa Bueno; Paula Agostinho; Adriana M Zago; Juliano Vieira; Pâmela Frühauf; José L Cechella; Cristina Wayne Nogueira; Sara M Oliveira; Caroline Rizzi; Roselia M Spanevello; Marta M F Duarte; Thiago Duarte; Odir A Dellagostin; Cinthia M Andrade
Journal:  Mol Neurobiol       Date:  2016-05-11       Impact factor: 5.590

Review 4.  Taming glutamate excitotoxicity: strategic pathway modulation for neuroprotection.

Authors:  Ming Jia; Steve A Noutong Njapo; Vaibhav Rastogi; Vishnumurthy Shushrutha Hedna
Journal:  CNS Drugs       Date:  2015-02       Impact factor: 5.749

5.  Exercise pre-conditioning reduces brain inflammation and protects against toxicity induced by traumatic brain injury: behavioral and neurochemical approach.

Authors:  Bibiana Castagna Mota; Leticia Pereira; Mauren Assis Souza; Luiz Fernando Almeida Silva; Danieli Valnes Magni; Ana Paula Oliveira Ferreira; Mauro Schneider Oliveira; Ana Flávia Furian; Leidiane Mazzardo-Martins; Morgana Duarte da Silva; Adair Roberto Soares Santos; Juliano Ferreira; Michele Rechia Fighera; Luiz Fernando Freire Royes
Journal:  Neurotox Res       Date:  2011-07-07       Impact factor: 3.911

6.  Rats with different thresholds to clonic convulsions induced by DMCM differ in the binding of [3H]-MK-801 and [3H]-ouabain in the membranes of brain regions.

Authors:  Marcos Brandão Contó; José Gilberto Barbosa de Carvalho; Marco Antonio Campana Venditti
Journal:  Neurochem Res       Date:  2012-03-01       Impact factor: 3.996

7.  Wallerian-like axonal degeneration in the optic nerve after excitotoxic retinal insult: an ultrastructural study.

Authors:  Sarabjit K Saggu; Hiren P Chotaliya; Peter C Blumbergs; Robert J Casson
Journal:  BMC Neurosci       Date:  2010-08-13       Impact factor: 3.288

8.  Diffuse axonal damage, myelin impairment, astrocytosis and inflammatory response following microinjections of NMDA into the rat striatum.

Authors:  Rafael R Lima; Joanilson Guimaraes-Silva; Jorge L Oliveira; Ana Maria R Costa; Renata D Souza-Rodrigues; Claudia D Dos Santos; Cristovam W Picanço-Diniz; Walace Gomes-Leal
Journal:  Inflammation       Date:  2007-09-25       Impact factor: 4.092

9.  Changes in gap junction expression and function following ischemic injury of spinal cord white matter.

Authors:  Karina Goncharenko; Eftekhar Eftekharpour; Alexander A Velumian; Peter L Carlen; Michael G Fehlings
Journal:  J Neurophysiol       Date:  2014-07-30       Impact factor: 2.714

10.  Neuronal activity and glutamate uptake decrease mitochondrial mobility in astrocytes and position mitochondria near glutamate transporters.

Authors:  Joshua G Jackson; John C O'Donnell; Hajime Takano; Douglas A Coulter; Michael B Robinson
Journal:  J Neurosci       Date:  2014-01-29       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.